FDA — authorised 30 April 1956
- Application: NDA010423
- Marketing authorisation holder: ROCHE
- Local brand name: LORFAN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Lorfan in United States
FDA authorised Lorfan on 30 April 1956
Marketing authorisations
FDA
- Marketing authorisation holder: ROCHE
- Status: approved
Lorfan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in United States
Frequently asked questions
Is Lorfan approved in United States?
Yes. FDA authorised it on 30 April 1956; FDA has authorised it.
Who is the marketing authorisation holder for Lorfan in United States?
ROCHE holds the US marketing authorisation.